Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed Dec 30, 2013 · 10-K · 91 days after period end · 0001062993-13-006497
derived · Computed from the longer spans the company filed.
| Metric | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.99M | -$674.23K | -$1.87M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Dec 30, 2013 · 91 d after period end
